Knowledge Graph · Hormone
GLP-1
Glucagon-like peptide-1 — an incretin hormone that stimulates insulin secretion and slows gastric emptying.
Authoritative sources
Evidence base
Randomized Controlled Trial · 2022 · Landmark
Tirzepatide Once Weekly for the Treatment of Obesity
New England Journal of Medicine · Jastreboff AM, Aronne LJ, Ahmad NN, et al. (SURMOUNT-1)
The pivotal trial that established tirzepatide (Zepbound / Mounjaro) as the most effective medication studied for weight loss to date.
Randomized Controlled Trial · 2021 · Landmark
Once-Weekly Semaglutide in Adults with Overweight or Obesity
New England Journal of Medicine · Wilding JPH, Batterham RL, Calanna S, et al. (STEP 1)
The pivotal trial that established semaglutide (Wegovy) as a highly effective medication for weight loss in adults without diabetes.
Where GLP-1 appears on Kindr Health
Journal
- Muscle Loss On Glp1 What The Research Showsprimary topic
Data hub
This page is part of Kindr Health's public Knowledge Graph. Content is for educational purposes only and is not medical advice.